RSS Feed For (NASDAQ:TEVA)

TEVAPHARMIND SP ADR (NASDAQ:TEVA)

57.10 -0 (-0%)
TEVAPHARMIND SP ADR (NASDAQ:TEVA) Delayed :
Previous Close $57.10    52 Week High $59.62 
Open $57.35    52 Week Low $41.70 
Day High $57.59    P/E N/A 
Day Low $56.72    EPS $0.00 
Volume 1,000       
More TEVA Info: Chart SEC Filings Profile Historical Options

Teva Pharmaceutical Industries Summary

Teva Pharmaceutical Industries Limited manufactures and sells generic and human pharmaceuticals, as well as active pharmaceutical ingredients in North America and internationally.

Executives

Shlomo Yanai - CEO & President

Links

http://www.tevapharm.com

What is this?Friends, Peers and Foes

Ticker # Stories Ticker # Stories
OGXI 8 MYL 8
PFE 7 PLX 7
WPI 4 CEPH 4
MRX 4 GSK 3
ACTI 3 GILD 3
BVF 3 SNY 3
View All Friends, Peers and Foes

StreetInsider Reports on TEVA by Category

View All Comments Comments on recent TEVA articles

JANET NADLER
on Jan 23, 2010
at 11:40 AM
EZCHIP-EZCH, NESS TECH-NSCT, COMMTOUCH-CTCH AND VOLTAIRE-VOLT PLEASE CHECK OUT THESE EXCELLENT COMPANIES AT GREAT PRICES.
Article: RBS Initiates Coverage on Teva Pharmaceutical (TEVA) with a Buy
JOE WOO
on Jan 8, 2010
at 07:56 PM
INSIDE INFO GS ANALYST FORGET TO LET ME KNOW TOO ON IPXL ON THURSDAY MID DAY
Article: Goldman Sachs Downgraded Generics to Neutral; MYL, IPXL Cut to Neutral
ANDREW OLIVER SATCHELL
on Nov 13, 2009
at 03:55 PM
ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
Iki
on Sep 2, 2009
at 05:15 PM
$10 is under esstimation !! Would like to emphsize that the holders can easily get more than $1B for FDA approved company, while $1B represent $13 of 76MM outstanding stocks. Profesionals can tell that the holder will not give up the company for much more...
Article: Hapoalim Securities Initiates Coverage on Protalix BioTherapeutics (PLX) with an Outperform; Attractive Entry Point
khalil
on Jul 24, 2009
at 09:29 AM
atripla stop letting people die because a patent stops affordable drugs. healthcare is a right not a privilege as it is in Amerika.
Article: Gilead Sciences (GILD) Receives Notification of ANDA Filing for Atripla by Teva Pharma (TEVA)
View All Comments

Comments on TEVA


No comments are currently available.